Mitochondrial disorder with OPA1 mutation lacking optic atrophy.

Area of Science:

• Genetics
• Neurology
• Mitochondrial Biology

Background:

• The OPA1 gene is crucial for mitochondrial dynamics and is highly expressed in the retina and optic nerve.
• OPA1 mutations are historically linked to autosomal dominant optic atrophy, a condition affecting vision.
• Recent findings suggested OPA1 mutations could be involved in multisystemic disorders with optic atrophy and muscle mitochondrial DNA deletions.

Observation:

• A patient presented with a multisystemic disorder and multiple mitochondrial DNA deletions in muscle.
• This patient harbored an in-frame deletion within the OPA1 gene.
• Notably, the patient did not exhibit optic atrophy, a hallmark symptom of OPA1-related disorders.

Findings:

• The study identified a novel OPA1 gene mutation (in-frame deletion) in a patient with a multisystemic disorder and muscle mitochondrial DNA deletions.
• This case demonstrates that optic atrophy is not an essential clinical feature in all OPA1-related mitochondrial disorders.
• The findings expand the clinical spectrum associated with OPA1 gene mutations.

Implications:

• OPA1 gene analysis should be considered in the diagnostic workup of patients with unexplained mitochondrial disorders, irrespective of the presence of optic atrophy.
• This broadens the diagnostic criteria for OPA1-related diseases.
• Understanding the diverse clinical presentations of OPA1 mutations is vital for accurate diagnosis and patient management.